Back to Search Start Over

Supplementary Figures from Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

Authors :
Kwok-Kin Wong
Glenn Dranoff
Peter S. Hammerman
Gordon J. Freeman
Scott J. Rodig
Lynette M. Sholl
Takeshi Shimamura
Geoffrey I. Shapiro
D. Neil Hayes
Matthew Meyerson
Pasi A. Janne
Travis J. Cohoon
Margaret Soucheray
Jacob B. Reibel
Mohit Butaney
Peter E. Fecci
Matthew D. Wilkerson
Trevor J. Pugh
Ellen M. Beauchamp
Andrew D. Cherniack
Oliver R. Mikse
Camilla L. Christensen
Jeremy H. Tchaicha
Abigail Altabef
Julian Carretero
Shohei Koyama
Esra A. Akbay
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file 2020K, Supplementary figures 1-11. For the mouse experiments tumor bearing lungs were classified as mildly sick and severely sick based on the tumor burden as determined by right lung lobe weights. Oncogene induced immunosuppressive environment manifested as compromised T cell function, elevation in the levels of tumor promoting cytokines, and changes in lung hematopoietic population was observed in the mildy sick mice in addition to the severely sick EGFR mutant mice. Anti PD-1 antibody treatment did not show efficacy in the Kras driven tumors despite the expression of the PD-1 ligand

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....1ae04d09fa1c83e0baed34f2e4825036
Full Text :
https://doi.org/10.1158/2159-8290.22530267